Literature DB >> 28823405

Sparing all salivary glands with IMRT for head and neck cancer: Longitudinal study of patient-reported xerostomia and head-and-neck quality of life.

Peter G Hawkins1, Jae Y Lee1, Yanping Mao2, Pin Li3, Michael Green1, Francis P Worden4, Paul L Swiecicki4, Michelle L Mierzwa1, Matthew E Spector5, Matthew J Schipper6, Avraham Eisbruch7.   

Abstract

BACKGROUND AND
PURPOSE: While parotid-sparing intensity modulated radiotherapy (IMRT) has demonstrated superiority to conventional RT in terms of observer-rated xerostomia, patient-reported outcome measures (PROMs) have only marginally improved. We investigated how sparing all salivary glands affects PROMs.
MATERIALS AND METHODS: Patients treated to the bilateral neck with all-gland-sparing IMRT answered xerostomia (XQ) and head-and-neck quality of life (HNQOL) questionnaires. Longitudinal regression was used to assess the relationship between questionnaire scores and mean bilateral parotid gland (bPG), contralateral submandibular gland (cSMG), and oral cavity (OC) doses. Marginal R2 and Akaike information criterion (AIC) were used for model evaluation.
RESULTS: 252 patients completed approximately 600 questionnaires. On univariate analysis, bPG, cSMG, and OC doses significantly correlated with XQ-summary, XQ-eating, and HNQOL-eating scores. On multivariate analysis, bPG and OC doses significantly correlated with XQ-summary, XQ-eating, and HNQOL-eating scores; and cSMG dose with HNQOL-summary. Combining doses to all three structures yielded the highest R2 for XQ-summary, XQ-rest, XQ-eating, and HNQOL-eating. In the 147 patients who received a mean cSMG dose ≤39Gy, there were no failures in contralateral level IB.
CONCLUSIONS: Reducing doses to all salivary glands maximizes PROMs. A cSMG dose constraint of ≤39Gy does not increase failure risk.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Head-and-neck cancer; IMRT; Patient-reported outcomes; Xerostomia

Mesh:

Year:  2017        PMID: 28823405     DOI: 10.1016/j.radonc.2017.08.002

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  25 in total

1.  Parotid sparing and quality of life in long-term survivors of locally advanced head and neck cancer after intensity-modulated radiation therapy.

Authors:  Silke Tribius; Sven Haladyn; Henning Hanken; Chia-Jung Busch; Andreas Krüll; Cordula Petersen; Corinna Bergelt
Journal:  Strahlenther Onkol       Date:  2020-12-30       Impact factor: 3.621

2.  A Deep Learning Model for Predicting Xerostomia Due to Radiation Therapy for Head and Neck Squamous Cell Carcinoma in the RTOG 0522 Clinical Trial.

Authors:  Kuo Men; Huaizhi Geng; Haoyu Zhong; Yong Fan; Alexander Lin; Ying Xiao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-06-13       Impact factor: 7.038

3.  The quantitative impact of joint peer review with a specialist radiologist in head and neck cancer radiotherapy planning.

Authors:  Kevin Chiu; Peter Hoskin; Amit Gupta; Roeum Butt; Samsara Terparia; Louise Codd; Yatman Tsang; Jyotsna Bhudia; Helen Killen; Clare Kane; Subhadip Ghoshray; Catherine Lemon; Daniel Megias
Journal:  Br J Radiol       Date:  2021-12-21       Impact factor: 3.039

4.  Transfer learning approach based on computed tomography images for predicting late xerostomia after radiotherapy in patients with oropharyngeal cancer.

Authors:  Annarita Fanizzi; Giovanni Scognamillo; Alessandra Nestola; Santa Bambace; Samantha Bove; Maria Colomba Comes; Cristian Cristofaro; Vittorio Didonna; Alessia Di Rito; Angelo Errico; Loredana Palermo; Pasquale Tamborra; Michele Troiano; Salvatore Parisi; Rossella Villani; Alfredo Zito; Marco Lioce; Raffaella Massafra
Journal:  Front Med (Lausanne)       Date:  2022-09-23

5.  Early Changes in Serial CBCT-Measured Parotid Gland Biomarkers Predict Chronic Xerostomia After Head and Neck Radiation Therapy.

Authors:  Benjamin S Rosen; Peter G Hawkins; Daniel F Polan; James M Balter; Kristy K Brock; Justin D Kamp; Christina M Lockhart; Avraham Eisbruch; Michelle L Mierzwa; Randall K Ten Haken; Issam El Naqa
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-07-10       Impact factor: 7.038

6.  Unilateral cochlea sparing in locoregionally advanced head and neck cancer: a planning study.

Authors:  L H Braun; K Braun; B Frey; S M Wolpert; H Löwenheim; D Zips; S Welz
Journal:  Strahlenther Onkol       Date:  2018-08-14       Impact factor: 3.621

7.  Predicting late radiation-induced xerostomia with parotid gland PET biomarkers and dose metrics.

Authors:  Joel R Wilkie; Michelle L Mierzwa; Keith A Casper; Charles S Mayo; Matthew J Schipper; Avraham Eisbruch; Francis P Worden; Issam El Naqa; Benjamin L Viglianti; Benjamin S Rosen
Journal:  Radiother Oncol       Date:  2020-04-06       Impact factor: 6.280

8.  Intensity-modulated proton therapy for oropharyngeal cancer reduces rates of late xerostomia.

Authors:  Jianzhong Cao; Xiaodong Zhang; Bo Jiang; Jiayun Chen; Xiaochun Wang; Li Wang; Narayan Sahoo; X Ronald Zhu; Rong Ye; Pierre Blanchard; Adam S Garden; C David Fuller; G Brandon Gunn; Steven J Frank
Journal:  Radiother Oncol       Date:  2021-04-08       Impact factor: 6.901

9.  Head and neck cancer patient images for determining auto-segmentation accuracy in T2-weighted magnetic resonance imaging through expert manual segmentations.

Authors:  Carlos E Cardenas; Abdallah S R Mohamed; Jinzhong Yang; Mark Gooding; Harini Veeraraghavan; Jayashree Kalpathy-Cramer; Sweet Ping Ng; Yao Ding; Jihong Wang; Stephen Y Lai; Clifton D Fuller; Greg Sharp
Journal:  Med Phys       Date:  2020-06       Impact factor: 4.071

10.  Design and Selection of Machine Learning Methods Using Radiomics and Dosiomics for Normal Tissue Complication Probability Modeling of Xerostomia.

Authors:  Hubert S Gabryś; Florian Buettner; Florian Sterzing; Henrik Hauswald; Mark Bangert
Journal:  Front Oncol       Date:  2018-03-05       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.